Huifeng Bio-Pharmaceutical Technology a developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production in Xi'an, China has entered into a contractual arrangement with Xi'an Qinba Xintong Medical.

Under the terms of this arrangement, Huifeng will take over operational control of Qinba and will receive a management fee equal to all of Qinba's profit.

Huifeng's CEO and founder Jing'An Wang stated that as a manufacturer of finished medical devices, Qinba will give Huifeng immediate access to pharmacy and medicine buyers.

Wang further noted that Huifeng is now commencing a vertical integration strategy intended to transform the company from a producer of raw materials for the Traditional Chinese Medicine industry to a full-scale pharmaceutical company supplying end products to consumers worldwide.